Who is legally designated as the Responsible Person for imported cosmetics?

When a cosmetic product manufactured outside the European Union (for instance, in the United States, Japan, or South Korea) is imported into an EU Member State, the legal importer becomes the Responsible Person by default, unless the manufacturer has formally designated an EU-based mandated representative in writing.

What is the difference between an EU Directive and an EU Regulation?

An EU Directive must be transposed into national law by each Member State (which historically generated national variations and trade friction under Directive 76/768/EEC). An EU Regulation is directly applicable and legally binding in all Member States upon enactment, without national transposition, creating a perfectly uniform European safety standard.

How does Regulation 1223/2009 regulate nanomaterials in cosmetics?

Regulation (EC) No 1223/2009 requires a dedicated advance notification on the CPNP portal 6 months prior to commercial placement for cosmetics containing nanomaterial ingredients (unless already authorized under Annexes IV, V, or VI). Furthermore, any nano-scale ingredient must be explicitly labeled with the suffix "[nano]" immediately following its INCI name on the packaging ingredient list.

European Cosmetic Regulation 1223/2009: Complete Compliance Guide

European Cosmetic Regulation (EC) No 1223/2009: The Definitive Compliance Guide for Manufacturers and Importers

Regulation (EC) No 1223/2009 is the unified, binding legislative framework governing every cosmetic product placed on the European Union and European Economic Area markets. Fully enacted in July 2013 to replace the former Cosmetic Directive 76/768/EEC, it harmonizes national technical standards to ensure the highest level of consumer health protection while enabling the unhindered movement of cosmetic goods across Member States. For brand owners, indie creators, contract manufacturers, and international importers, mastering this regulation is vital. Here is our authoritative compliance breakdown.

💡 Placing a cosmetic product on the European market? Guarantee full regulatory compliance for your cosmetic catalog. Estimate your dossier fees in 2 minutes with our configurator.

Launch the Configurator →

The 5 Fundamental Pillars of Regulation (EC) No 1223/2009

European cosmetic law is built upon five statutory pillars governing commercial market access:

Mandatory Designation of a Responsible Person (RP): Every cosmetic brand sold within the EU must designate a legal or natural entity established within the European Community (typically the EU manufacturer or EU importer). The RP assumes complete legal and regulatory liability for product safety and conformity.
Compilation of the Product Information File (PIF / DIP): A comprehensive technical dossier that must be retained by the RP for 10 years following the placement of the last production batch on the market, ready for immediate inspection by competent market surveillance authorities (such as DGCCRF in France).
Cosmetic Product Safety Report (CPSR): The scientific core of the PIF, drafted and officially signed by a credentialed cosmetic safety assessor (holding university degrees in pharmacy, toxicology, or medicine recognized in the EU).
Cosmetic Products Notification Portal (CPNP): Compulsory electronic notification of each finished cosmetic formula, packaging artwork, and framing formulation details before market launch.
Good Manufacturing Practice (ISO 22716 GMP): Mandatory adherence to ISO 22716 standards to guarantee hygiene, lot traceability, and consistent manufacturing quality controls.

Validating your formulas requires assembling a complete cosmetic PIF. Review our transparent packages in our dedicated PIF services guide.

🔬 Insights from our Cosmetic Safety Assessor

"Regulation (EC) No 1223/2009 enforces a total ban on animal testing (in force since 2004 for finished cosmetics and 2013 for all cosmetic ingredients). To prove safety without in vivo animal models, we conduct toxicological risk assessments by modeling Margins of Safety (MoS) based on the No Observed Adverse Effect Level (NOAEL) for each chemical constituent. This computational modeling is coupled with validated alternative in vitro assays (such as HET-CAM or reconstructed human epidermis - RhE) and clinical patch testing on human volunteers under dermatological supervision."

The Decisive Role of European Technical Annexes

Cosmetic formulation in Europe is governed by dynamic technical Annexes, regularly updated through European Commission regulations guided by the Scientific Committee on Consumer Safety (SCCS):

Annex II (Prohibited Substances): Lists over 1,600 banned chemical substances (including CMR categories 1A, 1B, and 2) that are strictly prohibited in cosmetics.
Annex III (Restricted Substances): Defines maximum permissible concentrations, purity requirements, and mandatory label warnings for conditionally allowed ingredients (such as retinol, salicylic acid, and fragrance allergens).
Annex IV (Colorants), Annex V (Preservatives), and Annex VI (UV Filters): Closed positive lists containing the only authorized substances permitted to fulfill these three specific technical functions. Any preservative, colorant, or UV filter not explicitly listed is strictly illegal.

The PIF serves as the mandatory master record demonstrating full Annex compliance. To understand dossier architecture, consult our comprehensive Product Information File guide, and explore physical testing requirements in our guides on cosmetic stability testing and cosmetic challenge testing.

⚠️ 3 Severe Violations Sanctioned by Market Surveillance Authorities

Missing CPNP notification: Placing cosmetic products on the market without an official CPNP notification number triggers immediate sales suspension, customs seizure, and substantial administrative fines.
Incomplete or unproduced PIF: Failure to make the PIF accessible to national health inspectors within 72 hours of an official request constitutes a criminal offense under European national laws.
Prohibited therapeutic claims: Making medical or curative claims (such as claiming to "cure eczema", "treat acne lesions", or "stop hormonal hair loss") reclassifies the product as an unauthorized medicinal drug.

European cosmetic regulatory compliance and ISO 22716 GMP standards

Frequently Asked Questions About Regulation (EC) No 1223/2009

Who is legally designated as the Responsible Person for imported cosmetics?: When a cosmetic product manufactured outside the European Union (for instance, in the United States, Japan, or South Korea) is imported into an EU Member State, the legal importer becomes the Responsible Person by default, unless the manufacturer has formally designated an EU-based mandated representative in writing.
What is the difference between an EU Directive and an EU Regulation?: An EU Directive must be transposed into national law by each Member State (which historically generated national variations and trade friction under Directive 76/768/EEC). An EU Regulation is directly applicable and legally binding in all Member States upon enactment, without national transposition, creating a perfectly uniform European safety standard.
How does Regulation 1223/2009 regulate nanomaterials in cosmetics?: Regulation (EC) No 1223/2009 requires a dedicated advance notification on the CPNP portal 6 months prior to commercial placement for cosmetics containing nanomaterial ingredients (unless already authorized under Annexes IV, V, or VI). Furthermore, any nano-scale ingredient must be explicitly labeled with the suffix "[nano]" immediately following its INCI name on the packaging ingredient list.

European cosmetic regulation compliance pricing and PIF drafting